The Fort Worth Press - DR Congo drug manufacturing plan sparks safety concerns

USD -
AED 3.672985
AFN 68.564771
ALL 93.747911
AMD 390.284429
ANG 1.810594
AOA 913.509585
ARS 1003.974897
AUD 1.540035
AWG 1.8025
AZN 1.695095
BAM 1.867656
BBD 2.028371
BDT 120.054049
BGN 1.8769
BHD 0.376987
BIF 2967.603314
BMD 1
BND 1.350013
BOB 6.941467
BRL 5.816273
BSD 1.004588
BTN 84.879318
BWP 13.715061
BYN 3.287735
BYR 19600
BZD 2.025029
CAD 1.399205
CDF 2869.999779
CHF 0.88787
CLF 0.035289
CLP 973.739762
CNY 7.248704
CNH 7.261055
COP 4389.25
CRC 510.697626
CUC 1
CUP 26.5
CVE 105.296581
CZK 24.37597
DJF 178.896958
DKK 7.15976
DOP 60.533139
DZD 133.646288
EGP 49.731703
ERN 15
ETB 125.19309
EUR 0.95985
FJD 2.27535
FKP 0.789317
GBP 0.79789
GEL 2.725037
GGP 0.789317
GHS 15.9733
GIP 0.789317
GMD 71.00031
GNF 8659.405931
GTQ 7.755077
GYD 210.182537
HKD 7.783795
HNL 25.38723
HRK 7.133259
HTG 131.897725
HUF 394.705022
IDR 15911.4
ILS 3.721435
IMP 0.789317
INR 84.47995
IQD 1316.106114
IRR 42104.999996
ISK 140.210173
JEP 0.789317
JMD 159.547343
JOD 0.709102
JPY 154.53898
KES 129.549834
KGS 86.499929
KHR 4051.853797
KMF 469.649893
KPW 899.999621
KRW 1405.050428
KWD 0.30774
KYD 0.837201
KZT 498.204702
LAK 22005.452662
LBP 89966.529634
LKR 292.295131
LRD 181.336364
LSL 18.178163
LTL 2.95274
LVL 0.60489
LYD 4.907395
MAD 10.047317
MDL 18.293632
MGA 4704.107261
MKD 58.76173
MMK 3247.960992
MNT 3397.999946
MOP 8.054107
MRU 39.953781
MUR 46.849963
MVR 15.450407
MWK 1742.028515
MXN 20.47025
MYR 4.467505
MZN 63.913532
NAD 18.17825
NGN 1691.080248
NIO 36.77015
NOK 11.128895
NPR 135.806643
NZD 1.71322
OMR 0.385062
PAB 1.004588
PEN 3.816004
PGK 4.044176
PHP 58.934986
PKR 279.238615
PLN 4.16856
PYG 7884.8734
QAR 3.662677
RON 4.775598
RSD 112.291014
RUB 103.632259
RWF 1380.387139
SAR 3.754515
SBD 8.36952
SCR 13.619873
SDG 601.500789
SEK 11.12161
SGD 1.34755
SHP 0.789317
SLE 22.584986
SLL 20969.504736
SOS 574.129781
SRD 35.404949
STD 20697.981008
SVC 8.790275
SYP 2512.529858
SZL 18.186159
THB 34.624501
TJS 10.699307
TMT 3.51
TND 3.178235
TOP 2.342101
TRY 34.561285
TTD 6.819267
TWD 32.597018
TZS 2655.858977
UAH 41.476647
UGX 3711.856071
UYU 42.810419
UZS 12855.000234
VES 46.269553
VND 25427.5
VUV 118.722009
WST 2.791591
XAF 626.409275
XAG 0.03196
XAU 0.000371
XCD 2.70255
XDR 0.766351
XOF 626.39432
XPF 113.885189
YER 249.902147
ZAR 18.098971
ZMK 9001.200433
ZMW 27.702577
ZWL 321.999592
  • RBGPF

    59.6900

    59.69

    +100%

  • CMSD

    0.1850

    24.445

    +0.76%

  • CMSC

    0.1200

    24.64

    +0.49%

  • SCS

    -0.0300

    13.04

    -0.23%

  • RIO

    0.1800

    62.57

    +0.29%

  • RELX

    0.6500

    45.76

    +1.42%

  • NGG

    -0.1700

    63.1

    -0.27%

  • BCC

    2.9500

    140.36

    +2.1%

  • GSK

    0.3500

    33.7

    +1.04%

  • AZN

    1.0600

    64.26

    +1.65%

  • RYCEF

    0.1800

    6.79

    +2.65%

  • VOD

    -0.1000

    8.84

    -1.13%

  • JRI

    0.0000

    13.23

    0%

  • BCE

    -0.3200

    26.68

    -1.2%

  • BTI

    -0.1000

    36.98

    -0.27%

  • BP

    0.4400

    29.52

    +1.49%

DR Congo drug manufacturing plan sparks safety concerns
DR Congo drug manufacturing plan sparks safety concerns / Photo: © AFP

DR Congo drug manufacturing plan sparks safety concerns

Sitting at his desk overlooking a pharmaceutical factory floor on the outskirts of the Congolese capital Kinshasa, Joss Ilunga Dijimba, 52, cracked a jovial smile.

Text size:

"It's not easy doing business in Congo," he said.

His family was forced to relocate the factory in the 1990s to survive bouts of mass looting. And nowadays, there are onerous taxes, customs duties, and problems retaining talented staff.

His company, which employs about 40 people and produces generics such as paracetamol, is one of a tiny number of drug manufacturers in the Democratic Republic of Congo, an impoverished nation roughly the size of Western Europe.

But a government plan to require hospitals and NGOs to buy more locally produced drugs could soon boost the fledgling pharmaceutical industry -- despite fears in some quarters that safety standards are far below international norms.

Several NGOs, some of which provide medical care in the DRC's conflict-torn east, have requested opt-outs.

At the small Pharmagros plant, behind barbed-wire walls near the Congo river, men in hairnets and white coats formulate medicines with imported precursor using lab equipment in airconditioned rooms.

"Promoting local industry's a good thing," said Dijimba, a University of Texas graduate, insisting that several Congolese firms, including his, maintained high standards.

"It could grow the middle class."

About 73 percent of the DRC's population of 90 million lives on under $1.9 a day, according to the World Bank. Most products in the African country are imported.

- 'At your own peril' -

The Congolese government has designated 35 drug molecules, including paracetamol, that medical facilities will be required to purchase in locally made form.

The government wants to stimulate business without banning imports, said Donatien Kabamb Kabey, the pharmaceuticals director at the DRC's health ministry.

He explained that all the molecules can be replaced with imported equivalents, suggesting that ibuprofen could replace paracetamol, for example.

Although not yet implemented, the policy already appears to be working.

Fifteen new pharma businesses are setting up in the DRC ahead of the new rules, Kabey said, which will add to the existing 24.

The policy was partly designed to encourage factories to return after fleeing the country in the 1990s, he added, when unpaid soldiers went on the rampage towards the end of ex-dictator Mobutu Sese Seko's reign.

But experts warn that Congolese-made medicines face a major challenge: reassuring doctors and patients that they meet regulatory standards.

"When you go to the private sector in Congo, you do it at your own peril," said Ed Vreeke, who runs the Belgium-based independent pharmaceutical auditing firm Quamed.

"They know darn well that the quality they produce is not good."

Vreeke said Congolese regulators had improved, but the country lacked the massive resources needed to properly perform audits, check labels, and inspect the chemical composition of drugs for safety.

Kabey, whose department at the health ministry oversees inspections, said standards had improved "enormously" in recent years, but did not provide further details.

He said the government was establishing a national quality-control lab.

- 'A huge thing' -

Shoddy or falsified medicines kill hundreds of thousands of people every year, according to the World Health Organization, mostly in poor countries.

The DRC's hot and humid climate also poses storage problems.

A 2021 study of both imported and locally produced eye drops sold in Kinshasa, for example, showed that three out of the seven products tested were substandard. The one sample manufactured in the DRC was contaminated.

Outside a pharmacy in Kinshasa's upmarket Gombe district, clutching a bag of medicines, 29-year-old corporate lawyer Joelle Mamputu said she didn't pay attention to where drugs were made but said she had "no prejudice".

However, a 52-year-old public servant named Olivier said there was "quite a difference" between Congolese and foreign drugs.

He added he would buy Congolese drugs were the quality the same.

Despite official assurances, major international NGOs such as Doctors Without Borders (MSF) and Medecins du Monde (MDM) have requested opt-outs from the purchasing requirements, several humanitarian workers said.

MSF declined to comment.

MDM confirmed it had asked for an exemption due to concerns over quality and capacity to meet demand.

"It's a huge thing," said one humanitarian who asked for anonymity, explaining that the new rules will affect all non-governmental organisations, hospitals and pharmacies.

Many aid workers understand the need to promote enterprise, he said, but there are internal disagreements about whether to compromise on quality.

"We need to have high quality standards for everyone, but the reality of the country is that sometimes it's impossible".

C.M.Harper--TFWP